Richard E. Pratley, MD | Ozempic and Wegovy Slash Kidney Disease Risks in People With Diabetes

In a recent study, health complications dropped by 24 percent in those taking semaglutide, the active ingredient in Ozempic and Wegovy. Dr. Prately was recently featured in an article on Everyday Health that discussed his recent research findings and how they can impact the larger population.


Recent News

12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News

Alcohol, Marijuana and Type 1 Diabetes:

Whether it's a backyard barbecue, a football game or dinner with friends, alcohol and marijuana are common parts of social life. For people with Type 1 diabetes (T1D), understanding how they affect...

News

The Science That Moves Medicine Forward:

Have you ever wondered how breakthrough medicines are developed, how doctors determine the most effective treatments, or how healthcare continues to advance? The answer lies in clinical research—the...

News

Advancing Cancer Research Closer to Home

At AdventHealth, we believe research is not separate from care. We believe the advancements made are what allow us to help our patients feel whole. That commitment is reflected in a new collaboration...

News

Moving More, Managing Better

For people living with type 1 diabetes, managing blood sugar is rarely simple. It’s a daily balancing act involving insulin, food, physical activity, technology and a constant stream of decisions.